Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.
Journal: Nature medicine
Published: August 29, 2025
Multicenter basket trial for central nervous system tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma.
Journal: Neuro-oncology
Published: August 22, 2025
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma.
Journal: Current oncology (Toronto, Ont.)
Published: July 25, 2025
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma.
Journal: Neuro-oncology advances
Published: July 24, 2025
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.
Journal: Acta neuropathologica
Published: June 20, 2025
Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma.
Journal: Neuro-oncology
Published: April 24, 2025
Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 06, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 23, 2024
A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR).
Journal: Cell reports. Medicine
Published: September 16, 2023
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
Journal: Journal of neuro-oncology
Published: September 05, 2023
Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
Journal: Neuro-oncology
Published: February 25, 2023
Last Updated: 09/26/2026